Search research articles
Contact Us
Filters
Showing results (191-200 of 587) with videos related to
Page
of 59
Sort By:
Diabetes, Obesity & Metabolism
|
October 21, 2024
Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: A meta-analysis
Ruoyang Jiao, Chu Lin, Xiaoling Cai, et al.
Plos One
|
May 10, 2016
Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Zhixia Li, Yuan Zhang, Xiaochi Quan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 29, 2017
Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial
Xiuying Zhang, Zhiwei Fang, Chunfang Zhang, et al.
Diabetes, Obesity & Metabolism
|
April 15, 2025
Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION-China study
Yingying Luo, Yiming Mu, Wei Chen, et al.
Frontiers in Endocrinology
|
May 21, 2025
Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial
Xinhui Yang, Xiuying Zhang, Chen Sun, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
January 31, 2026
Sarcopenia as a causal mediator in aging, obesity and central obesity related outcomes: A comprehensive analysis of NHANES, CHARLS and ELSA
Sitong Li, Qi Huang, Yingning Liu, et al.
Diabetes Research and Clinical Practice
|
November 3, 2017
Long exposure to type 2 diabetes and risk of non-fatal coronary heart disease in Chinese females and males: Findings from a China national cross-sectional study
Jing Li, Yingying Luo, Xiaohui Guo, et al.
Journal of Diabetes Investigation
|
October 14, 2017
No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-analysis
Xiaoling Cai, Xueying Gao, Wenjia Yang, et al.
Diabetes Technology & Therapeutics
|
December 6, 2016
DPP-4 Inhibitor Treatment in Chinese Type 2 Diabetes Patients: A Meta-Analysis
Xiaoling Cai, Xueying Gao, Wenjia Yang, et al.
Diabetes Research and Clinical Practice
|
October 20, 2009
Risk factors associated with the presence of diabetes in Chinese communities in Beijing
Xianghai Zhou, Linong Ji, Yingying Luo, et al.
Page
of 59
Search research articles
Search
Showing results (191-200 of 587) with videos related to
Sort By:
Page
of 59
Diabetes, Obesity & Metabolism
|
October 21, 2024
Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: A meta-analysis
Ruoyang Jiao, Chu Lin, Xiaoling Cai, et al.
Plos One
|
May 10, 2016
Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Zhixia Li, Yuan Zhang, Xiaochi Quan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 29, 2017
Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial
Xiuying Zhang, Zhiwei Fang, Chunfang Zhang, et al.
Diabetes, Obesity & Metabolism
|
April 15, 2025
Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION-China study
Yingying Luo, Yiming Mu, Wei Chen, et al.
Frontiers in Endocrinology
|
May 21, 2025
Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial
Xinhui Yang, Xiuying Zhang, Chen Sun, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
January 31, 2026
Sarcopenia as a causal mediator in aging, obesity and central obesity related outcomes: A comprehensive analysis of NHANES, CHARLS and ELSA
Sitong Li, Qi Huang, Yingning Liu, et al.
Diabetes Research and Clinical Practice
|
November 3, 2017
Long exposure to type 2 diabetes and risk of non-fatal coronary heart disease in Chinese females and males: Findings from a China national cross-sectional study
Jing Li, Yingying Luo, Xiaohui Guo, et al.
Journal of Diabetes Investigation
|
October 14, 2017
No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-analysis
Xiaoling Cai, Xueying Gao, Wenjia Yang, et al.
Diabetes Technology & Therapeutics
|
December 6, 2016
DPP-4 Inhibitor Treatment in Chinese Type 2 Diabetes Patients: A Meta-Analysis
Xiaoling Cai, Xueying Gao, Wenjia Yang, et al.
Diabetes Research and Clinical Practice
|
October 20, 2009
Risk factors associated with the presence of diabetes in Chinese communities in Beijing
Xianghai Zhou, Linong Ji, Yingying Luo, et al.
Page
of 59